BMY – Bristol Myers Squibb Co. – The global biopharmaceutical company’s shares are trading 2.15% higher this afternoon to $25.17 on news Pfizer, Inc., its partner in creating the drug apixaban, ended a trial of an experimental blood thinner that reportedly helps reduce stroke risk in certain patients. Bristol-Myers Squibb’s shares were also helped higher by an upgrade to ‘outperform’ from ‘market perform’ at Leerink Swann, and an upgrade to ‘buy’ from ‘hold’ at Citigroup. Earlier in the trading session BMY’s shares rose 4.5% to attain an intraday high of $25.76. Bullish options traders populating the July contract sold short 2,000 puts at the July $23 strike for an average premium of $0.31 per contract. Investors selling the puts may retain the full premium received on the transaction as long as Bristol-Myers’ shares exceed $23.00 through July expiration. Individuals short the puts are prepared to have shares of the underlying stock put to them at an effective price of $22.69 each if the put contracts land in-the-money by expiration day next month.
Affiliation: Interactive Brokers
Andrew Wilkinson is the senior market analyst at Interactive Brokers Group, where he provides daily commentary and analysis on U.S. equity options trading throughout the trading day. Andrew provides webinars designed to explain option-related trading scenarios covering futures, fixed income, forex and equities.
Interactive Brokers: Interactive Brokers offers direct market access to around 80 electronic global markets from a single account. Successful traders and investors understand that superior technology and lower trading costs can result in greater returns. For 32 years we have been building direct access trading technology that delivers real advantages to professionals worldwide. With consolidated equity capital of US $4.4 billion, IB and its affiliates exceed 1,000,000 trades per day. In addition, our prudent and conservative risk policies make Interactive Brokers a safe haven for your money. Discover some of the reasons why IB, the largest independent US broker/dealer, is the professional traders' and investors' choice.
Visit: Interactive Brokers